AgomAb Therapeutics NV American Depositary Shares (AGMB) News

Latest headlines that mention AGMB, newest first · each headline opens the original publisher

AGMB quote

Last price: $8.23
Day change: -0.60%
Next earnings: —

Quote & chart Expected move Insider trading IV rank history

AGMB headlines

latest coverage

Not much coverage yet. AGMB has appeared in only a few headlines lately; new stories show up here as publishers cover it.

Seeking Alpha News 18d ago

AgomAb Therapeutics NV (AGMB) Discusses Open-Label Extension Results of Phase IIa STENOVA Study in Fibrosing Crohn's Disease Transcript

General T2AGMB

Seeking Alpha News 1mo ago

AgomAb Therapeutics: Building A New Treatment Layer In Fibrosis

General T2AGMB

Seeking Alpha 2mo ago

AgomAb Therapeutics NV reports 1H results

General T2AGMB

Yahoo Finance 3mo ago

Is AgomAB Therapeutics NV (AGMB) Stock a Biotech Opportunity With Targeted Tissue Therapy Potential?

General T2AGMB

Seeking Alpha News 4mo ago

AgomAb Therapeutics: High Risk, High Reward Stock

General T2AGMB

AGMB news alerts

Get an alert by email or push when a new headline mentions AGMB.

More news

News headlines aggregated from third-party publishers via public RSS feeds and tagged with the tickers they mention. Frenzy Capital does not publish or endorse the content; clicking a headline opens the original publisher in a new tab.